| 1 | 1358101 | Kindling increases brain levels of NAAG and seizures reduce activity of a NAAG-hydrolyzing enzyme, NAALADase. | Epilepsy Res Suppl | 1992 |
2 |
| 2 | 1682006 | Reductions in acidic amino acids and N-acetylaspartylglutamate in amyotrophic lateral sclerosis CNS. | Brain Res | 1991 Aug 9 |
1 |
| 3 | 5309527 | [Determination of rheumatic and infectious arthritis activity by studying the heparin sedimented fraction of the blood psma]. | Vopr Revm | 1969 Oct-Dec |
1 |
| 4 | 7511053 | Expression of the prostate-specific membrane antigen. | Cancer Res | 1994 Apr 1 |
5 |
| 5 | 7543173 | Effect of exogenous testosterone replacement on prostate-specific antigen and prostate-specific membrane antigen levels in hypogonadal men. | J Surg Oncol | 1995 Aug |
4 |
| 6 | 7575102 | Abnormal excitatory neurotransmitter metabolism in schizophrenic brains. | Arch Gen Psychiatry | 1995 Oct |
6 |
| 7 | 8532851 | N-acetylaspartate in neuropsychiatric disorders. | Prog Neurobiol | 1995 Aug |
3 |
| 8 | 8753752 | Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. | Urology | 1996 Aug |
2 |
| 9 | 8950359 | Analysis of glycosylation of prostate-specific membrane antigen derived from LNCaP cells, prostatic carcinoma tumors, and serum from prostate cancer patients. | Prostate Suppl | 1996 |
9 |
| 10 | 9018338 | Monoclonal antibody 7E11.C5 staining of viable LNCaP cells. | Prostate | 1997 Jan 1 |
1 |
| 11 | 9123729 | Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase. | Urology | 1997 Mar |
2 |
| 12 | 9123743 | Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reaction. | Urology | 1997 Mar |
3 |
| 13 | 9187245 | Structure of membrane glutamate carboxypeptidase. | Biochim Biophys Acta | 1997 May 23 |
2 |
| 14 | 9215402 | Prostate-specific membrane antigen. | Prostate | 1997 Jul 1 |
1 |
| 15 | 9361299 | The nagging question of the function of N-acetylaspartylglutamate. | Neurobiol Dis | 1997 |
3 |
| 16 | 9375657 | Molecular cloning of a peptidase against N-acetylaspartylglutamate from a rat hippocampal cDNA library. | J Neurochem | 1997 Dec |
2 |
| 17 | 9516914 | Expression of potential target antigens for immunotherapy on primary and metastatic prostate cancers. | Clin Cancer Res | 1998 Feb |
1 |
| 18 | 9622670 | Hydrolysis of the neuropeptide N-acetylaspartylglutamate (NAAG) by cloned human glutamate carboxypeptidase II. | Brain Res | 1998 Jun 8 |
7 |
| 19 | 9685395 | Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II. | J Biol Chem | 1998 Aug 7 |
1 |
| 20 | 9809977 | Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line. | Cancer Res | 1998 Nov 1 |
2 |
| 21 | 9816319 | Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells. | Clin Cancer Res | 1996 Sep |
7 |
| 22 | 9838072 | Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene. | Biochim Biophys Acta | 1998 Nov 26 |
4 |
| 23 | 9882712 | Site-directed mutagenesis of predicted active site residues in glutamate carboxypeptidase II. | Mol Pharmacol | 1999 Jan |
7 |
| 24 | 10628836 | PSMA mimotope isolated from phage displayed peptide library can induce PSMA specific immune response. | Cell Res | 1999 Dec |
1 |
| 25 | 10640975 | Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues. | Cancer | 2000 Jan 15 |
2 |
| 26 | 10715144 | Dual function glutamate-related ligands: discovery of a novel, potent inhibitor of glutamate carboxypeptidase II possessing mGluR3 agonist activity. | J Med Chem | 2000 Mar 9 |
1 |
| 27 | 10739875 | Glutamyl hydrolase. pharmacological role and enzymatic characterization. | Pharmacol Ther | 2000 Mar |
1 |
| 28 | 10741705 | The development of biologic end points in patients treated with differentiation agents: an experience of retinoids in prostate cancer. | Clin Cancer Res | 2000 Mar |
1 |
| 29 | 10754531 | A dual-monoclonal sandwich assay for prostate-specific membrane antigen: levels in tissues, seminal fluid and urine. | Prostate | 2000 May 1 |
2 |
| 30 | 10790256 | NAALADase inhibitors: A novel approach to glutamate regulation. | Drug Discov Today | 2000 May |
1 |
| 31 | 10833385 | Generation of a baculovirus recombinant prostate-specific membrane antigen and its use in the development of a novel protein biochip quantitative immunoassay. | Protein Expr Purif | 2000 Jun |
1 |
| 32 | 10861758 | Suramin potently inhibits the enzymatic activity of PSM. | Prostate | 2000 Jun 15 |
12 |
| 33 | 11027414 | Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer. | Prostate | 2000 Oct 1 |
3 |
| 34 | 11092759 | Glutamate carboxypeptidase II: a polymorphism associated with lower levels of serum folate and hyperhomocysteinemia. | Hum Mol Genet | 2000 Nov 22 |
19 |
| 35 | 11102955 | Alterations of prostate biomarker expression and testosterone utilization in human LNCaP prostatic carcinoma cells by garlic-derived S-allylmercaptocysteine. | Prostate | 2000 Dec 1 |
4 |
| 36 | 11102961 | Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells. | Prostate | 2000 Dec 1 |
10 |
| 37 | 11170126 | In vivo model mimicking natural history of dog prostate cancer using DPC-1, a new canine prostate carcinoma cell line. | Prostate | 2001 Jan 1 |
1 |
| 38 | 11272670 | Utility of capromab pendetide (ProstaScint) imaging in the management of prostate cancer. | Tech Urol | 2001 Mar |
6 |
| 39 | 11351309 | Identification of prostate specific membrane antigen (PSMA) as the target of monoclonal antibody 107-1A4 by proteinchip; array, surface-enhanced laser desorption/ionization (SELDI) technology. | Int J Cancer | 2001 Jun 15 |
2 |
| 40 | 11375762 | Design of NAALADase inhibitors: a novel neuroprotective strategy. | Curr Med Chem | 2001 Jul |
12 |
| 41 | 11377343 | Comparison of anti-prostate-specific membrane antigen antibodies and other immunomarkers in metastatic prostate carcinoma. | Urology | 2001 Jun |
1 |
| 42 | 11449975 | [Synthesis and release of N-acetylaspartyl glutamate (NAAG) in medial giant axons in crayfish]. | Ross Fiziol Zh Im I M Sechenova | 2001 Apr |
10 |
| 43 | 11462970 | Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase). | J Med Chem | 2001 Feb 1 |
2 |
| 44 | 11525768 | Neuroprotection afforded by NAAG and NAALADase inhibition requires glial cells and metabotropic glutamate receptor activation. | Eur J Pharmacol | 2001 Aug 24 |
11 |
| 45 | 11559551 | In vitro targeted killing of prostate tumor cells by a synthetic amoebapore helix 3 peptide modified with two gamma-linked glutamate residues at the COOH terminus. | Cancer Res | 2001 Sep 15 |
1 |
| 46 | 11564433 | Synthesis and release of N-acetylaspartylglutamate (NAAG) by crayfish nerve fibers: implications for axon-glia signaling. | Neuroscience | 2001 |
21 |
| 47 | 11698060 | Neuroprotection mediated by glutamate carboxypeptidase II (NAALADase) inhibition requires TGF-beta. | Eur J Pharmacol | 2001 Oct 26 |
2 |
| 48 | 11708918 | Design and pharmacological activity of phosphinic acid based NAALADase inhibitors. | J Med Chem | 2001 Nov 22 |
1 |
| 49 | 11720792 | Mechanisms for clearance of released N-acetylaspartylglutamate in crayfish nerve fibers: implications for axon-glia signaling. | Neuroscience | 2001 |
3 |
| 50 | 11905994 | Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II. | J Neurochem | 2002 Feb |
10 |